Home/Filings/4/0001140361-17-001946
4//SEC Filing

AntriaBio, Inc. 4

Accession 0001140361-17-001946

$RZLTCIK 0001509261operating

Filed

Jan 12, 7:00 PM ET

Accepted

Jan 13, 7:31 PM ET

Size

5.7 KB

Accession

0001140361-17-001946

Insider Transaction Report

Form 4
Period: 2016-10-31
Fields Morgan
Chief Accounting Officer
Transactions
  • Award

    Stock Option (right to buy)

    2016-10-31+600,000600,000 total
    Exercise: $1.20Exp: 2026-10-31Common Stock (600,000 underlying)
Footnotes (2)
  • [F1]On October 31, 2016, the Reporting Person was granted 1,000,000 shares of common stock. Pursuant to Board approval and a Refresh Option Agreement, the number of shares was reduced for no consideration on December 27, 2016. An additional 240,000 shares may be issued upon certain performance only criteria.
  • [F2]The option vests in forty-eight equal installments beginning on the date so indicated and every month thereafter, such grant vested in full at 4 years.

Documents

1 file

Issuer

AntriaBio, Inc.

CIK 0001509261

Entity typeoperating
IncorporatedNV

Related Parties

1
  • filerCIK 0001509261

Filing Metadata

Form type
4
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 7:31 PM ET
Size
5.7 KB